Feb 29, 2024 ACIP Meeting - Pneumococcal Vaccines |
|
Current epidemiology of invasive pneumococcal disease and pneumococcal vaccine coverage in adults; Preliminary findings of the Pneumococcal pNeumonia Epidemiology, Urine serotyping, and Mental Outcomes (PNEUMO) US study; Phase 3 clinical trial data of PCV21; Post-licensure PCV20 safety data; PCV21 Policy Questions and Preliminary WG interpretations of EtR; Combined Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type B Conjugate, and Hepatitis B vaccine (Vaxelis®)
This video can also be viewed at https://www.cdc.gov/vaccines/videos/low-res/ACIPFeb2024/ACIP-9_Pneumococcal-Adjourn_02-29-2024_LowRes.mp4 |